Almost since antibiotics were first discovered, we’ve been aware bacteria can learn how to overcome these medicines, a phenomenon known as antimicrobial resistance.
The World Health Organization says we’re currently losing to the bugs, with resistance increasing and too few new antibiotics in the pipeline.
We wanted to know whether experts around the world think we will still have effective antibiotics in 50 years. Seven out of seven experts said yes.



FDA Fast-Track Drug Reviews Delayed Over Safety and Efficacy Concerns
Novo Nordisk Warns of Profit Decline as Wegovy Faces U.S. Price Pressure and Rising Competition
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal
Moderna to Pay Up to $2.25B to Settle LNP Patent Dispute Over COVID-19 Vaccine Technology
Sanofi Gains China Approval for Myqorzo and Redemplo, Strengthening Rare Disease Portfolio
Viking Therapeutics Sees Growing Strategic Interest in $150 Billion Weight-Loss Drug Market
Federal Appeals Court Blocks Trump-Era Hospital Drug Rebate Plan
TrumpRx.gov Highlights GLP-1 Drug Discounts but Offers Limited Savings for Most Americans
FDA Warns Novo Nordisk Over Misleading Ozempic Ad Claims
U.S. Vaccine Policy Shifts Under RFK Jr. Create Uncertainty for Pharma and Investors
Moderna Stock Drops After FDA Declines Review of mRNA Flu Vaccine 



